Email Editor Last year, the Dutch chemical conglomerate Akzo Nobel, N.V. (AS: AKZO) announced its intention to divest Organon BioSciences, its pharmaceutical division, either through an outright sale or by floating the unit in an IPO. It has found a willing buyer in...
Ten Deals Announced Worth A Combined $7.5 Billion Email Editor The Pharmaceutical sector generated 10 deals in February, worth a combined total of $7.5 billion. Two of the 10 were billion-dollar deals. The largest involves the $4.3 billion combination of Tanabe...
Triad Hospitals Privatized In $6.4 Billion Deal On Monday, March 19, Community Health Systems (NYSE: CYH) announced that it was taking advantage of the go-shop provision in the $6.4 billion deal to privatize Triad Hospitals (NYSE: TRH), discussed below, and would...
Hospitals Realign In The New York City Metropolitan Area Email Editor The start of the New Year continued some themes in the Hospital M&A market that closed the Old Year. One is the reappearance of not-for-profit operators, particularly Roman Catholic hospitals,...
Sector Leads Robust Consolidation In 2007 Email Editor The Medical Device sector posted a total of 14 deals during January, representing 17% of the month’s M&A deal volume. However, the sector attracted a disproportionate share of M&A dollars, $19.3 billion,...
Will Smith & Nephew Ultimately Join Forces With Biomet? Email Editor Rumors swirled in early December that medical device maker Smith & Nephew (NYSE: SNN) was preparing an $11.0 billion bid for rival Biomet, Inc. (NASDAQ: BMET). We now know that BMET was in...